نتایج جستجو برای: aml1

تعداد نتایج: 978  

Journal: :Cancer research 2006
David Shackelford Candia Kenific Agnieszka Blusztajn Samuel Waxman Ruibao Ren

Arsenic trioxide (ATO) has been found to be an effective treatment for acute promyelocytic leukemia patients and is being tested for treating other hematologic malignancies. We have previously shown that AML1/MDS1/EVI1 (AME), a fusion gene generated by a t(3;21)(q26;q22) translocation found in patients with chronic myelogenous leukemia during blast phase, myelodysplastic syndrome, or acute myel...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1998
D Levanon R E Goldstein Y Bernstein H Tang D Goldenberg S Stifani Z Paroush Y Groner

The mammalian AML/CBFalpha runt domain (RD) transcription factors regulate hematopoiesis and osteoblast differentiation. Like their Drosophila counterparts, most mammalian RD proteins terminate in a common pentapeptide, VWRPY, which serves to recruit the corepressor Groucho (Gro). Using a yeast two-hybrid assay, in vitro association and pull-down experiments, we demonstrate that Gro and its mam...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2012
Hai-Tong Fang Bo Zhang Xiao-Fen Pan Li Gao Tao Zhen Hong-Xia Zhao Liang Ma Jun Xie Zi Liu Xian-Jun Yu Xin Cheng Ting-Ting Feng Feng-Xiang Zhang Yong Yang Zhong-Guo Hu Guo-Qing Sheng Yong-Long Chen Sai-Juan Chen Zhu Chen Guang-Biao Zhou

The boronic acid dipeptide bortezomib inhibits the chymotrypsin-like activity of the 26S proteasome and shows significant therapeutic efficacy in multiple myeloma. However, recent studies suggest that bortezomib may have more complex mechanisms of action in treating cancer. We report here that the endocytosis and lysosomal degradation of the receptor tyrosine kinase C-KIT are required for borte...

2015
Mirle Schemionek Behzad Kharabi Masouleh Yvonne Klaile Utz Krug Katja Hebestreit Claudia Schubert Martin Dugas Thomas Büchner Bernhard Wörmann Wolfgang Hiddemann Wolfgang E. Berdel Tim H. Brümmendorf Carsten Müller-Tidow Steffen Koschmieder Zhengqi Wang

The adapter protein metastasis suppressor 1 (MTSS1) is implicated as a tumor suppressor or tumor promoter, depending on the type of solid cancer. Here, we identified Mtss1 expression to be increased in AML subsets with favorable outcome, while suppressed in high risk AML patients. High expression of MTSS1 predicted better clinical outcome of patients with normal-karyotype AML. Mechanistically, ...

2001
Ana Teresa Maia Anthony M. Ford G. Reza Jalali Christine J. Harrison

The occurrence of childhood acute lymphoblastic leukemia (ALL) in 2 of 3 triplets provided a unique opportunity for the investigation of leukemogenesis and the natural history of ALL. The 2 leukemic triplets were monozygotic twins and shared an identical, acquired TEL-AML1 genomic fusion sequence indicative of a single-cell origin in utero in one fetus followed by dissemination of clonal progen...

Journal: :Blood 2002
Joseph L Wiemels Zhijian Xiao Patricia A Buffler Ana T Maia Xiaomei Ma Brian M Dicks Martyn T Smith Luoping Zhang James Feusner John Wiencke Kathy Pritchard-Jones Helena Kempski Mel Greaves

Recent reports have established the prenatal origin of leukemia translocations and resultant fusion genes in some patients, including MLL-AF4 translocations in infants and TEL-AML1 translocations in children. We now report evidence for the prenatal origin of a translocation in childhood acute myeloid leukemia (AML). The t(8;21) AML1-ETO translocations were sequenced at the genomic level in 10 d...

Journal: :Blood 2003
James C Mulloy Jorg Cammenga Francisco J Berguido Kaida Wu Ping Zhou Raymond L Comenzo Suresh Jhanwar Malcolm A S Moore Stephen D Nimer

Hematopoiesis is a complex process involving hematopoietic stem cell (HSC) self-renewal and lineage commitment decisions that must continue throughout life. Establishing a reproducible technique that allows for the long-term ex vivo expansion of human HSCs and maintains self-renewal and multipotential differentiation will allow us to better understand these processes, and we report the ability ...

2012
Prateek Bhatia Jogeshwar Binota Neelam Varma RK Marwaha Pankaj Malhotra Subhash Varma

INTRODUCTION The incidence of common fusion transcripts in AML is 40-45%, but data from Indian sub-continent is limited. AIMS #ENTITYSTARTX00026; OBJECTIVES The aim of the present study is to note the incidence of common fusion transcripts of AML1-ETO, PML-RARA and CBFβ-MYH11 in adult and pediatric AML cases. MATERIALS #ENTITYSTARTX00026; METHODS A total of 116 AML cases diagnosed on bone...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید